From: EGFR associated expression profiles vary with breast tumor subtype
 | Basal-like | HER2+/ER- | Luminal A | Luminal B | Normal-like | p-value |
---|---|---|---|---|---|---|
# tumors | 53 | 35 | 123 | 55 | 29 | Â |
Cluster 1a | 68% | 37% | 12% | 56% | 14% | <0.0001 |
Cluster 2a | 89% | 49% | 5% | 49% | 7% | <0.0001 |
Cluster 3a | 77% | 51% | 11% | 47% | 0% | <0.0001 |
EGFRa | 68% | 20% | 27% | 18% | 41% | <0.0001 |
HER2a | 15% | 100% | 28% | 26% | 24% | <0.0001 |
HER4* | 9% | 3% | 50% | 38% | 31% | <0.0001 |
TGFAb | 74% | 37% | 17% | 25% | 38% | <0.0001 |
AREGa | 3% | 34% | 43% | 35% | 41% | <0.0001 |
EGF | 17% | 40% | 37% | 36% | 31% | 0.23 |
CRYABa | 70% | 11% | 33% | 4% | 48% | <0.0001 |
KRAS amplicona | 68% | 40% | 24% | 35% | 0% | <0.0001 |
KRAS genec | 32% | 37% | 33% | 38% | 21% | 0.36 |
HRASd | 32% | 66% | 17% | 64% | 7% | <0.0001 |
NRASa | 70% | 28% | 17% | 44% | 21% | <0.0001 |
PIK3CA | 30% | 17% | 36% | 36% | 41% | 0.28 |
PIK3R1a | 21% | 14% | 42% | 25% | 55% | 0.0012 |
AKT1a | 26% | 63% | 27% | 40% | 24% | <0.0001 |
AKT2* | 26% | 40% | 27% | 47% | 38% | 0.26 |
AKT3a | 51% | 14% | 39% | 9% | 45% | <0.0001 |
MEK1 | 53% | 46% | 25% | 29% | 24% | 0.023 |
MEK2e | 42% | 43% | 25% | 42% | 24% | 0.068 |
ERK1f | 30% | 26% | 31% | 42% | 41% | 0.49 |
ERK2g | 40% | 31% | 26% | 45% | 31% | 0.048 |